APA (7th ed.) Citation

CF, K., SJ, T., TP, S., CT, L., WC, L., CJ, H., . . . MH, C. (2025). Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression. Journal of psychopharmacology (Oxford, England), 39(6), 593. https://doi.org/10.1177/02698811251326939

Chicago Style (17th ed.) Citation

CF, Kao, Tsai SJ, Su TP, Li CT, Lin WC, Hong CJ, Bai YM, Tu PC, and Chen MH. "Monoamine Neurotransmitter-related Gene-based Genome-wide Association Study of Low-dose Ketamine in Patients with Treatment-resistant Depression." Journal of Psychopharmacology (Oxford, England) 39, no. 6 (2025): 593. https://doi.org/10.1177/02698811251326939.

MLA (9th ed.) Citation

CF, Kao, et al. "Monoamine Neurotransmitter-related Gene-based Genome-wide Association Study of Low-dose Ketamine in Patients with Treatment-resistant Depression." Journal of Psychopharmacology (Oxford, England), vol. 39, no. 6, 2025, p. 593, https://doi.org/10.1177/02698811251326939.